Usefulness of CT Fluoroscopy-guided Percutaneous Needle Biopsy in the Presence of Pneumothorax During Biopsy.
10.3348/jkrs.2006.55.2.143
- Author:
Dong Hyun O
1
;
Young Jun CHO
;
Yong Sung PARK
;
Cheol Mok HWANG
;
Keum Won KIM
;
Ji Hyung KIM
Author Information
1. Department of Radiology, College of Medicine, Konyang University, Korea. cyj126@paran.com
- Publication Type:Original Article
- Keywords:
Biopsies, technology;
Lung, CT;
Lung, biopsy;
Pneumothorax
- MeSH:
Biopsy*;
Biopsy, Needle*;
Emphysema;
Fluoroscopy;
Humans;
Lung;
Needles*;
Pleura;
Pneumothorax*
- From:Journal of the Korean Radiological Society
2006;55(2):143-148
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: When pneumothorax occurs during a percutaneous needle biopsy, the radiologist usually stops the biopsy. We evaluated the usefulness of computed tomographic (CT) fluoroscopy-guided percutaneous needle biopsy in the presence of pneumothorax during biopsy. MATERIALS AND METHODS: We performed 288 CT fluoroscopy guided percutaneous needle biopsies to diagnose the pulmonary nodules. Twenty two of these patients had pneumothorax that occurred during the biopsy without obtaining an adequate specimen. After pneumothoax occurred, we performed immediate CT fluoroscopy guided percutaneous needle biopsies using an 18-gauge cutting needle. We evaluated the success rate of the biopsies and also whether or not the pneumothorax progressed. We classified these patients into two groups according to whether the pneumothorax progressed (Group 2) or not (Group 1) by measuring the longest distance between the parietal pleura and the visceral pleura both in the early and late pneumothorax. Additionally, we analyzed the relationship between the progression of pneumothorax after biopsy and 1) the depth of the pulmonary nodule; 2) the number of biopsies; 3) the presence or absence of emphysema at the biopsy site; and 4) the size of the pulmonary nodule. RESULTS: Biopsy was successful in 19 of 22 nodules (86.3%). Of the 19 nodules, 12 (63.2%) were malignant and 7 (36.8%) were benign. Twelve patients (54.5%) were classified as group 1 and 10 patients (45.4%) as group 2. The distance between the lung lesion and pleura showed a statistically significant difference between these two groups: < or = 1 cm in distance for group 1 (81.8%) and group 2 (18.2%), and > 1 cm in distance for group 1 (30%) and group 2 (70%), p < 0.03. Yet the number of biopsies, the presence or absence of emphysema at the biopsy site and the size of the pulmonary nodules were not related to the progression of pneumothorax (p > 0.05). CONCLUSION: When early pneumothorax occurs during a biopsy, CT fluoroscopy guided percutaneous needle biopsy is an effective and safe procedure. Aggravation of pneumothorax after biopsy is affected by the depth of the pulmonary nodule.
